Cullinan Oncology Llc Stock Price on September 17, 2024
| CGEM Stock | USD 13.09 0.32 2.51% |
If you're considering investing in Cullinan Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cullinan Oncology stands at 13.09, as last reported on the 29th of November, with the highest price reaching 13.11 and the lowest price hitting 12.43 during the day. Cullinan Oncology LLC secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13% return per unit of risk over the last 3 months. Cullinan Oncology LLC exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cullinan Oncology's Mean Deviation of 2.85, risk adjusted performance of (0.1), and Standard Deviation of 3.62 to double-check the risk estimate we provide.
At this time, Cullinan Oncology's Common Stock is very stable compared to the past year. As of the 29th of November 2024, Total Stockholder Equity is likely to grow to about 476.4 M, while Capital Stock is likely to drop 2,933. . At this time, Cullinan Oncology's Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price To Book Ratio is likely to grow to 0.98, while Price Earnings Ratio is likely to drop (2.90). Cullinan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cullinan |
Sharpe Ratio = -0.1343
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CGEM |
Estimated Market Risk
| 3.6 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.48 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cullinan Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cullinan Oncology by adding Cullinan Oncology to a well-diversified portfolio.
Price Book 1.214 | Enterprise Value Ebitda (1.46) | Price Sales 26.8794 | Shares Float 38.5 M | Wall Street Target Price 33 |
Cullinan Oncology Main Headline on 17th of September 2024
Cullinan Therapeutics Receives Approval to Initiate its Glob... by finance.yahoo.com
Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for patients with systemic lupus erythematosus The trial will be conducted in multiple sites in Australia as well as other countries around the world CAMBRIDGE, Mass., Sept. 17, 2024 -- Cullinan Therapeutics, Inc. , a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today received Human Research Ethics Committee HR
Cullinan Oncology Valuation on September 17, 2024
It is possible to determine the worth of Cullinan Oncology on a given historical date. On September 17, 2024 Cullinan was worth 17.0 at the beginning of the trading date compared to the closed value of 17.24. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cullinan Oncology stock. Still, in general, we apply an absolute valuation method to find Cullinan Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cullinan Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cullinan Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 18.38 | 18.39 | 16.74 | 16.93 | 437,182 | |
09/17/2024 | 17.00 | 18.41 | 16.89 | 17.24 | 573,018 |
| 17.08 | 17.77 | 16.68 | 17.23 | 442,727 |
| Backtest Cullinan Oncology | | | Cullinan Oncology History | | | Cullinan Oncology Valuation | Previous | Next |
Cullinan Oncology Trading Date Momentum on September 17, 2024
| On September 18 2024 Cullinan Oncology LLC was traded for 17.23 at the closing time. The top price for the day was 17.77 and the lowest listed price was 16.68 . The trading volume for the day was 442.7 K. The trading history from September 18, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.06% . The overall trading delta against the current closing price is 1.51% . |
Cullinan Oncology LLC Fundamentals Correlations and Trends
By evaluating Cullinan Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cullinan Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cullinan financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cullinan Oncology Stock history
Cullinan Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cullinan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cullinan Oncology LLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cullinan Oncology stock prices may prove useful in developing a viable investing in Cullinan Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.5 M | 42.3 M | |
| Net Income Applicable To Common Shares | 127.9 M | 134.3 M |
Cullinan Oncology Quarterly Net Working Capital |
|
Cullinan Oncology Stock Technical Analysis
Cullinan Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cullinan Oncology Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Cullinan Oncology LLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cullinan Oncology November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Cullinan Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cullinan Oncology shares will generate the highest return on investment. By undertsting and applying Cullinan Oncology stock market strength indicators, traders can identify Cullinan Oncology LLC entry and exit signals to maximize returns
Cullinan Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cullinan Oncology's price direction in advance. Along with the technical and fundamental analysis of Cullinan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cullinan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.24) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cullinan Oncology LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cullinan Oncology. If investors know Cullinan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cullinan Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.84) | Return On Assets (0.20) | Return On Equity (0.27) |
The market value of Cullinan Oncology LLC is measured differently than its book value, which is the value of Cullinan that is recorded on the company's balance sheet. Investors also form their own opinion of Cullinan Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cullinan Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cullinan Oncology's market value can be influenced by many factors that don't directly affect Cullinan Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cullinan Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cullinan Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cullinan Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.